Factor | Non-ESBL group | ESBL group | p-value |
---|---|---|---|
(n = 189) | (n = 22) | ||
Administered empirical antibiotics | 0.814 | ||
With aminoglycoside | |||
Third-generation cephalosporin + aminoglycoside | 111 (58.7) | 13 (59.1) | |
Aminopenicillin/β-lactamase inhibitor + aminoglycoside | 34 (18.0) | 4 (18.2) | |
Second-generation cephalosporin + aminoglycoside | 4 (2.1) | 1 (4.5) | |
Without aminoglycoside | |||
Third-generation cephalosporin | 25 (13.2) | 3 (13.6) | |
Aminopenicillin/β-lactamase inhibitor | 2 (1.1) | 1 (4.5) | |
Second-generation cephalosporin | 1 (0.5) | 0 (0.0) | |
Others | 10 (5.3) | 0 (0.0) | |
No therapy | 2 (1.1) | 0 (0.0) | |
Appropriateness of empirical antibiotic therapya | 182 (100.0) | 20 (90.9) | 0.011 |
Antibiotic duration (days) | |||
Total | 13.0 (12.0–14.0) | 14.0 (13.0–16.0) | 0.048 |
Intravenousb | 6.0 (5.0–7.0) | 6.0 (5.0–7.0) | 0.742 |
Oralc | 7.0 (7.0–9.0) | 7.0 (6.0–10.5) | 0.477 |
Aminoglycosidesd | 6.0 (4.0–7.0) | 6.0 (5.0–7.0) | 0.170 |
Fever duration after antibiotic therapy (days)e | 1.0 (0.0–2.0) | 1.0 (0.0–1.3) | 0.573 |
Response to empirical antibiotic therapy | |||
Disappearance of fevere | 172 (92.5) | 20 (90.9) | 0.680 |
Bacterial eradication on the urinef | 174 (98.9) | 21 (100.0) | 1.000 |
Follow-up time of urine culture (days)f | 2.0 (2.0–3.0) | 2.0 (1.0–2.5) | 0.611 |